Press release
Candidiasis Therapeutics Market Growing Rapidly by 2031- Cidara Therapeutics Inc., NovaDigm Therapeutics Inc., Amplyx Pharmaceuticals Inc
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/candidiasis-therapeutics-market
The Candidiasis Therapeutics market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Candidiasis therapeutics refer to the treatments used to manage and cure infections caused by Candida species, a type of yeast that can lead to candidiasis. This condition can affect various parts of the body, including the mouth, throat, genital area, and bloodstream. Therapeutics for candidiasis include antifungal medications such as azoles (e.g., fluconazole), echinocandins (e.g., caspofungin), and polyenes (e.g., amphotericin B). These treatments aim to eradicate the yeast infection, alleviate symptoms, and prevent recurrence, often tailored to the severity of the infection and the patient's overall health.
Forecast Growth Projected:
The Global Candidiasis Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Candidiasis Therapeutics Market:
Cidara Therapeutics Inc., NovaDigm Therapeutics Inc., Amplyx Pharmaceuticals Inc., Astellas Pharma Inc., Basilea Pharmaceutica Ltd., Merck, SCYNEXIS, Inc., Pacgen Biopharmaceuticals, Viamet Pharmaceuticals Holdings, LLC, Mycovia Pharmaceuticals Inc., Novabiotics Limited, Bayer AG
Segment Covered in the Candidiasis Therapeutics Market:
By Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis
By Drug Class: Polyene (Nystatin (Mycostatin and others), Amphotericin B (Fungizone, Amphocin)), Azole Antifungals (Fluconazole (Diflucan), Itraconazole (Sporanox), Voriconazole (Vfend), Posaconazole (Noxafil)), Topical azoles (Clotrimazole (Mycelex, Femizole-7), Butoconazole (Femstat-3, Gynazole-1), Miconazole vaginal (Monistat, Micatin), Tioconazole (Vagistat-1), Terconazole vaginal (Terazol-7, Terazol-3)), Glucan synthesis inhibitors (echinocandins) (Caspofungin (Cancidas), Micafungin (Mycamine), Anidulafungin (Eraxis)), Antimetabolite (Flucytosine (Ancobon)), Allylamines (Terbinafine (Daskil, Lamisil), Others)
By Route of Administration: Oral, Parenteral, Topical
By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Others
Regional Analysis:
The global Candidiasis Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/candidiasis-therapeutics-market
Regional Analysis:
The global Candidiasis Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Candidiasis Therapeutics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Candidiasis Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Candidiasis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/candidiasis-therapeutics-market
FAQs
How fast is the Candidiasis Therapeutics Market growing?
The Candidiasis Therapeutics Market will exhibit a CAGR of 5.3% during the forecast period, 2024-2031.
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Candidiasis Therapeutics Market Growing Rapidly by 2031- Cidara Therapeutics Inc., NovaDigm Therapeutics Inc., Amplyx Pharmaceuticals Inc here
News-ID: 3622678 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Contact Probe Market to 2035: DataM Intelligence Forecasts Steady Growth Driven …
The global Contact Probe Market is projected to expand from USD 1.45 billion in 2024 to USD 2.35 billion by 2033, at a CAGR of 5.5%. Growth is fueled by rising demand for semiconductor testing, miniaturization of electronic components, and the rapid expansion of 5G, automotive electronics, and consumer devices. According to DataM Intelligence, the United States and Asia (especially Japan and South Korea) are the primary innovation hubs for…
Asia-Pacific Spatial Computing Market 2025 | Rising Demand, Growth Drivers & Inv …
Market Size and Growth
Asia-Pacific Spatial Computing Market reached US$ 44.77 billion in 2024 and is expected to reach US$ 302.58 billion by 2032, growing with a CAGR of 27.5% during the forecast period 2025-2032.
Key Development:
Asia-Pacific Spatial Computing: Recent Developments
✅ United States: Industry Developments
✅ In July 2025, Arm announced a $250 million partnership with Malaysia to develop AI chips locally, marking its first such agreement with a country.
✅ In June…
United States Eye Tracking in Healthcare Market 2025 | Growth Drivers & Investme …
Market Size and Growth
The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Optain Health secured $26 million in Series A funding to expand its AI-driven retinal imaging technology, Oculomics, enhancing early diagnosis of eye diseases…
Latin America Pain Management Drugs Market 2025 | Growth Drivers, Market Expansi …
Market Size and Growth
The Latin America pain management drugs market reached US$ 4,069.52 million in 2024 and is expected to reach US$ 6,576.78 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.
Key Development:
Latin America: Recent Developments in Pain Management Drugs
✅ In January 2025, SteinCares announced a commercialization agreement with Molteni Farmaceutici to expand access to Oramorph®, a novel morphine oral solution, in Ecuador, Brazil…
More Releases for Candidiasis
Candidiasis Market New Product Development & Latest Trends
Introduction
Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such as Candida auris are raising global concerns due to their high resistance to antifungal drugs. Candidiasis can affect the mouth (oral thrush), genital areas, bloodstream, and internal organs, with systemic infections often proving life-threatening, especially in immunocompromised patients.
The growing prevalence of hospital-acquired infections (HAIs), rising…
Rising Fungal Infection Rates Fueling Growth In The Candidiasis Therapeutics Mar …
The Candidiasis Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Candidiasis Therapeutics Market Size and Projected Growth Rate?
Recent years have seen consistent growth in the size of the market for candidiasis therapeutics. This is predicted to further expand from $3.19 billion…
Acute Vulvovaginal Candidiasis Market Beyond Douching: New Treatment Options Dri …
Acute Vulvovaginal Candidiasis Market worth $ 485.54 Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acute Vulvovaginal Candidiasis Market- by Drug Type (Clotrimazole, Nystatin, Fluconazole, , Terbinafine, Terconazole and Other Drug Types), Route of Administration (Oral, Intravenous and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast…
Recurrent Vulvovaginal Candidiasis Market - Defeating Recurrent Vulvovaginal Can …
Newark, New Castle, USA: The "Recurrent Vulvovaginal Candidiasis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Recurrent Vulvovaginal Candidiasis Market: https://www.growthplusreports.com/report/recurrent-vulvovaginal-candidiasis-market/8832
This latest report researches the industry structure,…
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with…
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape.
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin…
